Recent News

Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30
Program here.
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, .
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici.
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici.
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo.
CERIMED OBTAINS DUAL ISO 9001:2015 AND NF X50-900:2016 CERTIFICATION FOR ITS PRE-CLINICAL RADIOLOGICAL AND NUCLEAR SERVICE AND INNOVATION ACTIVITIES
On June 5, 2022, the European Center for Research in Medical Imaging (CERIMED, UMS AMU CNRS 2012) obtained dual ISO 9001:2015 and NF-X50-900 certification for its pre-clinical
Symposium’21 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”
Program here.
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility

Last Publications (10/428)

Tsagkaris, S, McClelland, V, Fialho, D, Lumsden, DE, Kaminska, M, Guedj, E et al.. Motor and sensory neurophysiology in relation to [¹⁸F]FDG PET imaging in children with dystonia. Brain Commun. 2025;7 (3):fcaf151. doi: 10.1093/braincomms/fcaf151. PubMed PMID:40585814 PubMed Central PMC12203795.
Guedj, E, Campion, JY, Horowitz, T, Barthélémy, F, Khalfa, S, El-Hage, W et al.. Emotional stress during the COVID-19 lockdown: how negative X/Twitter posts correlated with changes in the brain’s fear network. Front Nucl Med. 2025;5 :1575026. doi: 10.3389/fnume.2025.1575026. PubMed PMID:40557036 PubMed Central PMC12186706.
Bobot, M, Bruyat, A, Thomas, L, Fernandez, S, Brodovitch, A, Boucraut, J et al.. Blood-brain barrier permeability in CKD: link with inflammation and cognitive and mood impairment in rats. Behav Brain Res. 2025; :115693. doi: 10.1016/j.bbr.2025.115693. PubMed PMID:40513958 .
Mecerli, S, Cazauvieilh, V, Vial, R, Colson, S, Roman, C, Bobot, M et al.. [Effectiveness of virtual reality interventions on anxiety and depressive symptoms in hemodialysis patients: A systematic review]. Nephrol Ther. 2025;21 (3):1-10. doi: 10.1684/ndt.2025.122. PubMed PMID:40495768 .
Deux, JF, Habert, P. Cardiac MRI in Fabry disease: T1 mapping as a quantitative biomarker for treatment monitoring. Diagn Interv Imaging. 2025;106 (7-8):243-244. doi: 10.1016/j.diii.2025.04.005. PubMed PMID:40280801 .
Verger, A, Doyen, M, Heyer, S, Goehringer, F, Bruyere, A, Kaphan, E et al.. Reorganization of brain connectivity in post-COVID condition: a ¹⁸F-FDG PET study. EJNMMI Res. 2025;15 (1):28. doi: 10.1186/s13550-025-01217-7. PubMed PMID:40158051 PubMed Central PMC11954761.
Bodin, S, Damiana, TST, Previti, S, Balasse, L, Ali, L, Rémond, E et al.. N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake. J Med Chem. 2025;68 (7):7280-7290. doi: 10.1021/acs.jmedchem.4c02844. PubMed PMID:40111113 .
Andrade, A, Bachmann, M, Bobot, M, Bruchfeld, A, Fridolin, I, Mani, LY et al.. Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors. Nephrol Dial Transplant. 2025;40 (Supplement_2):ii18-ii27. doi: 10.1093/ndt/gfae256. PubMed PMID:40080092 PubMed Central PMC11997786.
Boutanquoi, PM, Pommerolle, L, Dondaine, L, Tanguy, J, Bellaye, PS, Biziorek, L et al.. An antisense oligonucleotide targeting the heat-shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis. Br J Pharmacol. 2025;182 (12):2713-2729. doi: 10.1111/bph.17470. PubMed PMID:40033950 .
Yu, Q, Vidal, V. Less is More? Balancing Innovation with Safety is Essential to the Advancement of the Emborrhoid Technique. Cardiovasc Intervent Radiol. 2025;48 (3):395-397. doi: 10.1007/s00270-025-03988-x. PubMed PMID:39994025 .

Search PubMed

Dernières Publications (10/428)

Tsagkaris, S, McClelland, V, Fialho, D, Lumsden, DE, Kaminska, M, Guedj, E et al.. Motor and sensory neurophysiology in relation to [¹⁸F]FDG PET imaging in children with dystonia. Brain Commun. 2025;7 (3):fcaf151. doi: 10.1093/braincomms/fcaf151. PubMed PMID:40585814 PubMed Central PMC12203795.
Guedj, E, Campion, JY, Horowitz, T, Barthélémy, F, Khalfa, S, El-Hage, W et al.. Emotional stress during the COVID-19 lockdown: how negative X/Twitter posts correlated with changes in the brain’s fear network. Front Nucl Med. 2025;5 :1575026. doi: 10.3389/fnume.2025.1575026. PubMed PMID:40557036 PubMed Central PMC12186706.
Bobot, M, Bruyat, A, Thomas, L, Fernandez, S, Brodovitch, A, Boucraut, J et al.. Blood-brain barrier permeability in CKD: link with inflammation and cognitive and mood impairment in rats. Behav Brain Res. 2025; :115693. doi: 10.1016/j.bbr.2025.115693. PubMed PMID:40513958 .
Mecerli, S, Cazauvieilh, V, Vial, R, Colson, S, Roman, C, Bobot, M et al.. [Effectiveness of virtual reality interventions on anxiety and depressive symptoms in hemodialysis patients: A systematic review]. Nephrol Ther. 2025;21 (3):1-10. doi: 10.1684/ndt.2025.122. PubMed PMID:40495768 .
Deux, JF, Habert, P. Cardiac MRI in Fabry disease: T1 mapping as a quantitative biomarker for treatment monitoring. Diagn Interv Imaging. 2025;106 (7-8):243-244. doi: 10.1016/j.diii.2025.04.005. PubMed PMID:40280801 .
Verger, A, Doyen, M, Heyer, S, Goehringer, F, Bruyere, A, Kaphan, E et al.. Reorganization of brain connectivity in post-COVID condition: a ¹⁸F-FDG PET study. EJNMMI Res. 2025;15 (1):28. doi: 10.1186/s13550-025-01217-7. PubMed PMID:40158051 PubMed Central PMC11954761.
Bodin, S, Damiana, TST, Previti, S, Balasse, L, Ali, L, Rémond, E et al.. N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake. J Med Chem. 2025;68 (7):7280-7290. doi: 10.1021/acs.jmedchem.4c02844. PubMed PMID:40111113 .
Andrade, A, Bachmann, M, Bobot, M, Bruchfeld, A, Fridolin, I, Mani, LY et al.. Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors. Nephrol Dial Transplant. 2025;40 (Supplement_2):ii18-ii27. doi: 10.1093/ndt/gfae256. PubMed PMID:40080092 PubMed Central PMC11997786.
Boutanquoi, PM, Pommerolle, L, Dondaine, L, Tanguy, J, Bellaye, PS, Biziorek, L et al.. An antisense oligonucleotide targeting the heat-shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis. Br J Pharmacol. 2025;182 (12):2713-2729. doi: 10.1111/bph.17470. PubMed PMID:40033950 .
Yu, Q, Vidal, V. Less is More? Balancing Innovation with Safety is Essential to the Advancement of the Emborrhoid Technique. Cardiovasc Intervent Radiol. 2025;48 (3):395-397. doi: 10.1007/s00270-025-03988-x. PubMed PMID:39994025 .

Search PubMed